Welcome to...The UCLA Endocrine Surgical Unit
 

Schedule an Appointment
Endocrine Home
About Us
Our Expert Team
Our Services
First Visit for Patients
Patient Education
  Getting started
  High Calcium
  Parathyroid 4D-CT Scan
  Parathyroid Surgery Success
  Parathyroid Surgery Priorities
  Benefits of parathyroid surgery
  Thyroid and Parathyroid Disease
  Find a Surgeon
  Parathyroid Surgery FAQ
  About endocrine surgery
  History of endocrine surgery
  Outcomes in endocrine surgery
  Health Care Quality and Safety
  Reputable Affiliates
  Diseases we treat
  Endocrine encyclopedia
  Adrenocortical Carcinoma
  Pheochromocytoma
  Thyroid Cancer in Children
  Thyroid Cancer Staging
Scar Gallery
For Referring Physicians
Distance Surgery Program
International Patients
Insurance Questions
Map-Directions-Parking
Contact Us
Patient Experiences
Endocrine Resources
Fellowship Training
Research Opportunities
Site Map

UCLA Health System





Patient Education - Endocrine Encyclopedia

Endocrine Surgery Encyclopedia

Hypercalcemia

HypercalcemiaDefinition:
Hypercalcemia is an excessive amount of calcium in the blood.

Causes, incidence, and risk factors:
Calcium is important in the body. It is an important part of the bone, and it exists as a charged particle called an ion in the blood and inside cells. Calcium is important to many body functions including bone formation, muscle contraction, nerve and brain function, and the release of hormones.

Parathyroid hormone (PTH) and vitamin D regulate calcium balance in the body. PTH is produced by the parathyroid glands -- four small glands located in the neck behind the thyroid gland. Vitamin D is obtained from exposure of skin to sunlight, and from dietary sources such as fortified dairy products, egg yolks, fish, and fortified cereals.

Primary hyperparathyroidism is the most common cause of hypercalcemia and is due to excess PTH. The drug lithium, used in treating bipolar disorder, may increase PTH release and cause hypercalcemia. A genetic mutation that affects the body's ability to regulate calcium is seen in familial hypocalciuric hypercalcemia (FHH), a benign (non-cancerous) condition.

Blood calcium can also be high despite low levels of PTH, however. Some malignant tumors (for example, lung cancers, breast cancer) produce PTH-related peptide (PTHrP) which increases blood calcium. Excess vitamin D (hypervitaminosis D) from diet or inflammatory diseases can also cause hypercalcemia. Kidney failure, adrenal gland failure, hyperthyroidism, prolonged immobilization, use of a class of diuretics called thiazides, and ingestion of massive amounts of calcium (milk-alkali syndrome) are other potential causes.

Hypercalcemia affects from 0.1 to 1% of the population. The widespread ability to measure blood calcium since the 1960s has improved detection of the condition, and today most patients with hypercalcemia have no symptoms. Women over the age of 50 are most likely to be hypercalcemic, usually due to primary hyperparathyroidism.

Symptoms:

Skeletal:

  • Bone pain
  • Loss of height
  • Bowing of the shoulders
  • Spinal column curvature
  • Pathological fractures

Kidney:

  • Flank pain
  • Frequent urination
  • Frequent thirst

Abdominal:

  • Pain
  • Nausea
  • Vomiting
  • Poor appetite
  • Constipation

Psychological:

  • Irritability
  • Memory loss
  • Apathy
  • Depression
  • Dementia
  • Coma

Muscular:

  • Weakness
  • Muscle twitches
  • Muscle atrophy

Signs and tests:

  • High serum total and/or ionized calcium
  • High serum PTH level (hyperparathyroidism)
  • High urine calcium (hyperparathyroidism, other causes)
  • Low urine calcium (FHH)
  • High vitamin D level (hypervitaminosis D, granulomatous diseases)
  • High serum PTHrP (certain cancers)

Treatment:
Treatment is directed at the underlying cause of hypercalcemia whenever possible. In cases of hyperparathyroidism, surgery may be needed to remove the abnormal parathyroid gland and cure the hypercalcemia.

When hypercalcemia is mild and caused by primary hyperparathyroidism, patients may be followed closely by their doctor over time. A new medication named cinacalcet has been shown to lower calcium levels in the blood by reducing parathyroid hormone production.

Severe hypercalcemia causing symptoms and requiring hospitalization is treated aggressively with the following:

  • Intravenous fluids
  • Bisphosphonates (drugs that stop bone breakdown and absorption by the body, such as pamidronate or etidronate)
  • Calcitonin
  • Glucocorticoids (steroids, for hypervitaminosis D that is not medication-related)
  • Hemodialysis (for hypercalcemia that is unresponsive to treatment and is life-threatening)

Support Groups:

Expectations (prognosis):
Prognosis depends on the underlying cause of hypercalcemia. Patients with mild hyperparathyroidism or hypercalcemia with a treatable cause (for example, primary hyperparathyroidism, dietary hypervitaminosis D) may not suffer complications from hypercalcemia.

Patients with hypercalcemia secondary to conditions such as cancer or granulomatous disease may have a poor prognosis due to the underlying disease itself rather than to the hypercalcemia. The complications of prolonged hypercalcemia are uncommon today.

Complications:

Skeletal

  • Fractures
  • Osteoporosis
  • Bone cysts

Kidney

  • Nephrocalcinosis (calcification of the kidney)
  • Kidney stones
  • Dehydration
  • Kidney failure

Gastrointestinal

  • Pancreatitis
  • Peptic ulcer disease
  • Hypertension

Psychosocial

  • Difficulty concentrating or thinking
  • Depression

Calling your health care provider:
Contact your physician or health care provider if you have a family history of hypercalcemia, family history of hyperparathyroidism, or if symptoms of hypercalcemia occur.

Prevention:
Most causes of hypercalcemia cannot be prevented. Women over the age of 50 should see their health care provider regularly and have their blood calcium screened periodically.

Hypercalcemia from calcium and vitamin D supplements can be avoided by contacting your health care provider for advice if you are taking supplements without a prescription.

References:
Taniegra ED. Hyperparathyroidism. Am Fam Physician. 2004; 69(2): 333-9.

Carroll MF. A practical approach to hypercalcemia. Am Fam Physician. 2003; 67(9): 959-66.

Ariyan CE. Assessment and management of patients with abnormal calcium. Crit Care Med. 2004; 32(4 Suppl): S146-54.


Review Date: 5/12/2006
Reviewed By: Robert Hurd, MD, Department of Biology, College of Arts and Sciences, Xavier University, Cincinnati, OH. Review provided by VeriMed Healthcare Network.

A.D.A.M. qualityA.D.A.M., Inc. is accredited by URAC, also known as the American Accreditation HealthCare Commission (www.urac.org). URAC's accreditation program is an independent audit to verify that A.D.A.M. follows rigorous standards of quality and accountability. A.D.A.M. is among the first to achieve this important distinction for online health information and services. Learn more about A.D.A.M.'s editorial policy, editorial process and privacy policy. A.D.A.M. is also a founding member of Hi-Ethics and subscribes to the principles of the Health on the Net Foundation (www.hon.ch).

The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed medical professional should be consulted for diagnosis and treatment of any and all medical conditions. Call 911 for all medical emergencies. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. © 1997- 2007 A.D.A.M., Inc. Any duplication or distribution of the information contained herein is strictly prohibited.

A.D.A.M. logo


Diseases of the Endocrine System

Tests and studies: